ECM
PRCT icon

ExodusPoint Capital Management’s Procept Biorobotics PRCT Stock Holding History

ExodusPoint Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-237,198
Closed -$7.46M – 1986
2025
Q4 		$7.46M Buy
+237,198
New +$7.87M 0.06% 338
2025
Q3 		– Sell
-48,021
Closed -$2.77M – 1918
2025
Q2 		$2.77M Buy
+48,021
New +$2.72M 0.02% 626
2023
Q2 		– Sell
-338,950
Closed -$9.63M – 2174
2023
Q1 		$9.63M Buy
+338,950
New +$12M 0.08% 287
2022
Q2 		– Sell
-16,863
Closed -$590K – 2340
2022
Q1 		$590K Buy
+16,863
New +$406K 0.01% 1439

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ExodusPoint Capital Management's PRCT Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 237,198 shares — an estimated $7.46M sold.

ExodusPoint Capital Management first reported a position in PRCT in Q1 2022 and held it in 4 quarters. The position peaked at $9.63M in Q1 2023. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 237,198 Procept Biorobotics shares in Q1 2026, an estimated $7.46M.
  • ExodusPoint Capital Management first reported a position in Procept Biorobotics in Q1 2022 and held it in 4 quarters.
  • ExodusPoint Capital Management's Procept Biorobotics position peaked at $9.63M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.